Cervical cancer is the second leading cause of cancer deaths in women worldwide and HPV
infection is responsible for the development of this cancer. Effective vaccination against HPV …

Cervical cancer, which is caused by oncogenic types of the human papillomavirus (HPV), is
the second most common cancer in women, responsible for 274,000 deaths worldwide in …

Persistent infection by 'high risk'genotypes of human papilloma virus (HPV) is necessary but
not sufficient for the development of over 98% of cervical cancers. Thus the development of …

The identification of human papillomavirus (HPV) as a cause of cervical cancer and its
precursor lesions indicates that HPV vaccines can potentially be used to prevent or treat …

New prophylactic HPV vaccines have the power to prevent many HPV infections, thus
reducing the burden of HPV-associated diseases. Two vaccines composed of HPV L1 …

Vaccines to prevent infection with high-risk human papillomaviruses (HPV) will help protect
women against cervical cancer, and some are likely to be available within the next year. One …

Genital human papilloma virus (HPV), the most common sexually transmitted disease in the
United States, is associated with cervical cancer in women, and penile cancers in men. The …

Human papillomavirus (HPV) infection is the known cause of almost all cases of cervical
cancer. An understanding of the HPV genome has allowed the development of two …

Cervical cancer is one of the most common cancers threatening women's health, and the
persistent infection of high-risk human papillomavirus (HPV) is closely related to the …

Cervical cancer is a malignant neoplasm arising from cells that originate in the cervix uteri. It
is the second most prevalent cancer among women. It can have several causes; an infection …